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Abstract
 
Activation-induced cell death in macrophages has been observed, but the mechanism remains
 
largely unknown. Activation-induced cell death in macrophages can be independent from
caspases, and the death of activated macrophages can even be triggered by the pan-caspase in-
hibitor benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone (zVAD). Here, we show that
this type of macrophage death can occur in the septic mouse model and that toll-like receptor
(TLR)-2 or TLR4 signaling is required in this process. We conclude that Nur77 is involved in
the macrophage death because Nur77 expression correlates with cell death, and cell death is re-
duced significantly in Nur77-deficient macrophages. The extracellular signal–regulated kinase
pathway, which is downstream of TLR2 or TLR4, and myocyte-specific enhancer binding
factor 2 (MEF2) transcription factor activity, which is up-regulated by zVAD, are required for
Nur77 induction and macrophage death. Reporter gene analysis suggests that Nap, Ets, Rce,
and Sp1 sites in the Nur77 promoter are regulated by TLR4 signaling and that MEF2 sites in
the Nur77 promoter are regulated by zVAD treatment. MEF2 transcription factors are constitu-
tively expressed and degraded in macrophages, and zVAD increases MEF2 transcription factor
activity by preventing the proteolytic cleavage and degradation of MEF2 proteins. This paper
delineates the dual signaling pathways that are required for Nur77 induction in macrophages
and demonstrates a role of Nur77 in caspase-independent cell death.
Key words: AICD • LPS • zVAD • MEF2
 
Introduction
 
Programmed cell death, often referred to as apoptosis, is a
genetically regulated, self-destructive cellular process found
in metazoans. It eliminates individual cells when they are
no longer needed in development, tissue remodeling, or
immune regulation, as well as in various diseases (1). In
immune cells, apoptosis is a key phenomenon in what is
referred to as activation-induced cell death (AICD).
 
*
 
 Dur-
ing T cell maturation, AICD is a mechanism for T cells to
negatively select thymocyte clones through TCR-medi-
ated stimuli (2, 3). AICD in B cell lymphocytes is involved
 
in antigen tolerance, which is initiated by antigen interaction
with the B cell receptor (4). A similar term, activation-
induced apoptosis, has been used to describe IFN-
 

 
 and
zymosan- or phorbol ester–induced death of macrophages
(5). AICD in T and B cells has been a focus of intense
study and the underlying molecular mechanisms have been
well-described (3, 4, 6, 7). However, little is known about
the mechanism of AICD in macrophages.
Macrophage death occurs in vitro and in vivo, and has
many different causes. Phagocytosis of infectious microor-
ganisms by macrophages is a part of the host response to
infection (8). Infectious microbial pathogens can be killed
by macrophages, and their components are strong stimuli
of macrophage activation. Activation of macrophages can
lead to their own death if the macrophages are exposed to
viruses, such as bovine herpes virus-1, or cytokines, such as
IFN-
 

 
 and -
 

 
 (2, 9–11). Priming macrophages with IFN-
 

 
is known to be required for macrophages to eliminate
highly resistant microorganisms (12). Although IFN-
 

 
–
primed macrophages are crucial for host defense, they are
also dangerous because they can cause extensive local dam-
age if uncontrolled (13, 14). Teleological reasoning holds
that the evolution of susceptible death in these cells may be
a mechanism to control activated macrophages. The cell
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*
 
Abbreviations used in this paper: 
 
AICD, activation-induced cell death;
CLP, cecal ligation and puncture; EMSA, electrophoretic mobility shift
assay; ERK, extracellular signal–regulated kinase; MEF2, myocyte-spe-
cific enhancer binding factor 2; NF, nuclear factor; PG, peptidoglycan;
PI, propidium iodide; TLR, toll-like receptor; zVAD, benzyloxycarbo-
nyl-Val-Ala-Asp-fluoromethyl ketone.
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death of activated macrophages could be a mechanism to
control the level of inflammation.
Activation of macrophages with various stimuli, includ-
ing the gram-negative bacterial cell wall product LPS at
physiologically relevant concentrations, does not lead to
cell death in vitro. Our recent work shows that treatment
of macrophages with a pan-caspase inhibitor benzyloxycar-
bonyl-Val-Ala-Asp-fluoromethyl ketone (zVAD), which
has no effect on the viability of resting macrophages, in-
duces the death of activated macrophages (15). We have
demonstrated that this cell death is a caspase-independent
process. Macrophage death induced by LPS 
 
 
 
zVAD and
LPS 
 
 
 
IFN-
 

 
 may share some common mechanisms be-
cause LPS 
 
 
 
IFN-
 

 
–induced macrophage death is also in-
dependent of the known proapoptotic caspases (unpub-
lished data). LPS 
 
 
 
IFN-
 

 
–induced macrophage death
appears to be a complicated process because both direct and
indirect mechanisms are likely involved (9, 10, 16). Nitric
oxide, induced by LPS 
 
 
 
IFN-
 

 
, is an indirect trigger of
macrophage death, but a nitric oxide–independent mecha-
nism also exists (9, 10, 16). LPS 
 
 
 
zVAD–induced macro-
phage death was quicker and more effective than LPS 
 

 
IFN-
 

 
–induced cell death, and was triggered directly by
targeting intracellular molecules. Because LPS 
 
 
 
zVAD–
induced cell death of macrophages could be simpler than
other in vitro systems, such as LPS 
 
 
 
IFN-
 

 
–induced mac-
rophage death, we have used this system to study the
mechanism of macrophage death. In addition, this system
may be used to address the mechanism of caspase-indepen-
dent cell death. Studying zVAD-promoted cell death of ac-
tivated macrophages will also help in understanding cas-
pases as drug targets for treating inflammatory diseases (17).
Recent papers have shown that a pan-caspase inhibitor im-
proves survival in a murine sepsis model (18). Caspases, as
targets of gene therapy in rheumatoid arthritis, have been
reported to have a therapeutic advantage (19). The effect of
zVAD on the viability of macrophages could influence the
outcome of these therapeutic interventions.
There is no doubt that caspases play a key role in apop-
tosis of many different cells. However, caspases are not in-
dispensable in promoting cell death, as evidenced by the
failure of pan-caspase inhibitors (such as zVAD and boc-D)
to prevent cell death in some cell death programs (20–23).
In many cases, zVAD completely blocked the nuclear
events associated with apoptosis, but failed to prevent cell
death (20–22). In our work, zVAD even promoted cell
death (15). Thus, there seems to be parallel caspase-depen-
dent and -independent cell death pathways (24). The
mechanism of caspase-independent cell death is poorly de-
fined. Death of activated macrophages promoted by pan-
caspase inhibitors could be an extreme case of caspase-inde-
pendent cell death.
Apoptosis can be mediated through multiple pathways.
Mitochondrial release of apoptogenic factors, such as cyto-
chrome 
 
c
 
, Smac/DIABLO, and apoptosis-inducing factor,
occurs in many apoptotic processes (25). The release of
these factors from mitochondria can be regulated by cas-
pases, Bcl-2 family proteins, translocation of tumor sup-
 
pressor p53, or the orphan nuclear receptor Nur77 (also
known as TR3 or NGFI-B; reference 26). Nur77 was
identified as an immediate early gene that is responsive to
TCR signaling under conditions leading to thymocyte
apoptosis, or serum or phorbol ester stimulation of quies-
cent fibroblasts (27, 28). Structurally, Nur77 belongs to the
steroid receptor family (29). It is referred to as an “orphan”
receptor because its ligand is unknown. It has been implied
that Nur77 induction plays a crucial role in AICD of T
cells. Both transcription activity and mitochondrial target-
ing of Nur77 has been suggested to be required for cell
death (30, 31).
We reported previously that macrophage cell death
could be triggered by costimulation with LPS and zVAD
(15). In this paper, we explore the role of Nur77 and delin-
eate its regulatory pathways in macrophage death induced
by the costimulation LPS and zVAD.
 
Materials and Methods
 
Purified LPS from Escherichia coli O111.
 
B4 was purchased
from List Biological Laboratories. Synthetic phosphodiester CpG
(5
 

 
-AACGTTAACGTTAACGTT-3
 

 
) was obtained from Sigma-
Genosys. Peptidoglycan (PG) was purchased from Sigma-Aldrich.
Flagellin was a gift from Dr. A. Aderem (University of Washing-
ton, Seattle, WA). Polyclonal antibodies for myocyte-specific en-
hancer binding factor 2 (MEF2)-C and MEF2D were raised
against peptides YGNPRNSPGLLVSPGNLNKNMQAKSP and
LLEDKYRRASEELDGLFRRYGSTVPA, respectively.
 
Sepsis Model.
 
Polymicrobial sepsis was induced using cecal li-
gation and puncture (CLP) as described previously (32) with
slight modifications. In brief, female ND4 mice weighing 20–25 g
were anesthetized with an intramuscular injection of a mixture of
80 mg/kg/body weight ketamine and 16 mg/kg/body weight
xylazine. The cecum was ligated and punctured twice with a 25-
gauge needle. Sham-operated mice received cecal manipulation
only, without ligation. The presence of sepsis was verified by
checking the formation of bacterial colonies in agar plate from 30
 

 
l of blood. Approximately 10–500 colonies were obtained from
CLP mice, whereas none were obtained from sham-operated
mice. 10 mg/kg of caspase inhibitor, zVAD (Enzyme System
Products), or its diluent DMSO, was injected 60 min after CLP
by intraperitoneal injection and repeated every 12 h. Peritoneal
macrophages were obtained 26–30 h after CLP.
 
Nur77 and Toll-like Receptor (TLR)2/4 Knockout Mice. 
 
Het-
erozygote Nur77
 

 
/
 

 
 knockout mice were provided by J. Mil-
brandt (Washington University, St. Louis, MO). Homozygote
Nur77 wild-type
 
(
 

 
/
 

 
)
 
 
 
and knockout
 
(
 

 
/
 

 
)
 
 mice were obtained
from the same littermates by heterozygote mating. TLR4
knockout mice were provided by S. Akira (Osaka University,
Osaka, Japan).
 
Preparations of Peritoneal Macrophages and FACS
 
®
 
 Analysis.
 
Resident peritoneal macrophages were obtained from mice by
normal saline lavage as described previously (33). Mice other than
those used for the sepsis model received intraperitoneal injection
of 3% thioglycollate 4 d before the preparation of peritoneal mac-
rophages. Peritoneal macrophages were harvested by lavage of the
peritoneal cavity with 5 ml of normal saline. The cells were
washed twice in FACS
 
®
 
 buffer (phosphate-buffered saline with
1% fetal bovine serum [vol/vol] and 0.01% sodium azide [wt/
vol]), and 
 

 
10
 
6
 
 cells were labeled for 20 min with 1 
 

 
g each of
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APC-conjugated monoclonal rat anti–mouse CD11b (BD Bio-
sciences), RPE-cy5–conjugated rat anti–mouse F4/80 (Serotec),
and R-PE–conjugated hamster anti–mouse CD11c monoclonal
antibodies (BD Biosciences). After washing with annexin labeling
solution, the cells were incubated with FITC-conjugated annexin
V (Roche Molecular Biochemicals) for 30 min. Macrophages
were identified as CD11b-positive, F4/80-positive, and CD11c-
negative cells, and the degree of cell death was quantified by an-
nexin V–positive cells as described previously (15).
 
Cell Culture. 
 
Peritoneal macrophages were plated on plastic
tissue culture plates and incubated at 37
 

 
C for 2 h. The nonad-
herent cells were removed by repeated washing three times with
fresh DMEM, and the adherent macrophage cells were cultured
overnight in DMEM medium supplemented with 10% fetal bo-
vine serum, 100 U/ml penicillin, 100 
 

 
g/ml streptomycin, and 2
mM glutamine (supplemented DMEM). The murine monocyte/
macrophage cell line, RAW 264.7, was maintained in the supple-
mented DMEM. All experiments were performed in supple-
mented DMEM.
 
Cell Viability Assays. 
 
The extent of cell death was measured
using either crystal violet or propidium iodide (PI; Sigma-Aldrich)
permeability analysis. The crystal violet uptake assays were per-
formed in a 96-well plate as described previously (34). PI staining
was assessed after incubation of the cells with 2 
 

 
g/ml PI, fol-
lowed by FACS
 
®
 
 analysis. The extent of cell death was analyzed
using either a dot plot or a histogram against the PI fluorescence.
 
Total Cell Lysate Preparation, Western Blot Analysis, and Electro-
phoretic Mobility Shift Assay (EMSA). 
 
Extraction of total cell ly-
sate and Western blot analysis for MEF2s were performed as de-
scribed previously (15). Antibody for MEF2A was purchased
from Santa Cruz Biotechnology, Inc. and antibodies for MEF2C
and MEF2D were raised in rabbit against their specific peptides.
For EMSA, nuclear extracts of RAW 264.7 cells were incubated
with a double-stranded, 
 
32
 
P-labeled oligonucleotide containing
an MEF2 binding site as a probe (35).
 
Plasmids. 
 
The wild-type and mutant pGL2-TR3/Nur77
(
 

 
93 to 
 

 
17) reporter genes were provided by X. Liu (Danish
Cancer Society, Copenhagen, Denmark). Reporter genes for
wild-type and mutant MEF2-response Nur77 promoter (
 

 
307 to
 

 
242; provided by J. Liu [Center for Cancer Research, Massa-
chusetts Institute of Technology, Cambridge, MA]) reporters
were constructed by cutting wild-type TR3/Nur77 (
 

 
93 to
 

 
17) reporter gene with KpnI and MluI, and inserting the pro-
moter sequences into KpnI site. The dominant active form of
TR3/Nur77 mutant (lacking the DNA binding domain) plasmid
was provided by X-K. Zhang (Burnham Institute, La Jolla, CA).
 
Transfection of Plasmids and Reporter Gene Analysis. 
 
Raw
264.7 cells were transiently transfected by electrophoration (300 V,
950 
 

 
F). After electrophoration, cells were washed and plated in
6-well plates and stabilized for 12–16 h in supplemented DMEM
before starting treatments. Luciferase was extracted according to
the manufacturer’s instructions (Promega) and activity was deter-
mined by a bioluminescent assay. Activities in individual samples
were normalized on the basis of protein content.
 
RT-PCR and Real-time PCR. 
 
Total RNA from RAW
246.7 cells was prepared as per the manufacturer’s instructions
(RNeasy Mini kit; QIAGEN). RT-PCR was performed using
0.5 
 

 
g of total RNA as a template to detect the expression of
Nur77, Nurr1, and Nor1, using One-step RT-PCR kit
(QIAGEN). The primers used were as follows: for Nur77,
5
 

 
-CTCTCCGAACCGTGACACTT-3
 

 
 (5
 

 
-primer) and 5
 

 
-
GGAAGGAGAGCGGAAGAGAT-3
 

 
 (3
 

 
-primer); for Nurr1,
5
 

 
-CAGCACAGGCTACGACGTCAA-3
 

 
 (5
 

 
-primer) and
 
5
 

 
-AGCCCTCACAAGTGCGAACAC-3
 

 
 (3
 

 
-primer); and for
Nor1, 5
 

 
-GAGAGGTCGTCTGCCTTCCAA-3
 

 
 (5
 

 
-primer)
and 5
 

 
-GTCCCTTCCTCTGGTGGTCCT-3
 

 
 (3
 

 
-primer). For
the quantitative PCR analysis, 0.5 
 

 
g of total RNA from RAW
246.7 cells was used to prepare cDNA using Omniscript RT kit
(QIAGEN) with oligo(dT
 
12
 
) as a primer, which was quantified by
real-time PCR using SYBR green PCR master mix kit (Applied
Biosystems). The primers used for Nur77, Nurr1, Nor1, and
MEF2s were as follows: for Nur77, 5
 

 
-CTCGCCATCTAC-
ACCCAACT-3
 

 
 (5
 

 
 primer) and 5
 

 
-AGCCTTAGGCAA-
CTGCTCTG-3
 
 
 
(3
 

 
 primer); for Nurr1, 5
 

 
-CATGGACCT-
CACCAACACTG-3
 
 
 
(5
 

 
 primer) and 5
 

 
-ACAGGGGC-
ATTTGGTACAAG-3
 
 
 
(3
 

 
 primer); for Nor1, 5
 

 
-TCAGC-
CTTTTTGGAGCTGTT-3
 

 
 (5
 

 
-primer) and 5
 

 
-TGAAGTC-
GATGCAGGACAAG-3
 
 
 
(3
 

 
 primer); for MEF2A primers,
5
 

 
-TTGAGCACTACAGACCTCACG-3
 

 
 (5
 

 
 primer) and
5
 

 
-TGCACCAGTATTTCCAATCAA-3
 
 
 
(3
 

 
 primer); for MEF2C
primer, 5
 

 
-GGATGAGCGTAACAGACAGGT-3
 

 
 (5
 

 
 primer)
and 5
 

 
-ATCAGTGCAATCTCACAGTCG-3
 
 
 
(3
 

 
 primer); and
for MEF2D primer, 5
 

 
-GAGAAGATGGGGAGGAAAAAG-3
 

 
(5 primer) and 5-GCCTTCTTCATCAGTCCAAAC-3
(3 primer).
Results
Pan-caspase Inhibitor, zVAD, Promotes Cell Death of Acti-
vated Macrophages. We demonstrated previously that co-
stimulation of macrophages with LPS and pan-caspase in-
hibitor zVAD results in cell death (15). Because this cell
death occurs quickly and is a direct result of LPS  zVAD
treatment, we believe this system can be used to study the
mechanism of macrophage death. To further characterize
this system, we first examined whether zVAD promoted
activated macrophage death in vivo. Macrophages activated
in septic models were used in our experiments. Sepsis was
induced in mice with CLP, as described in Materials and
Methods. 10 mg/kg body weight zVAD or control vehicle
(DMSO) was injected peritoneally in CLP and sham mice.
Sepsis induced by CLP was verified by the presence of bac-
teria in the blood by counting the bacterial colony forma-
tion in blood cultures. Peritoneal macrophages were har-
vested 26–30 h after CLP or sham surgery. FACS® analysis
was used to identify macrophages (CD11b, F4/80, and
CD11c) in the peritoneal isolates and to analyze the level
of cell death in these macrophages. Because apoptotic cells
are cleared quickly in vivo, we needed to measure early
markers of cell death to detect the apoptotic cells. Translo-
cation of phosphatidylserine from the inner to the outer
layer of the plasma membrane is an early event in apoptosis;
therefore, we used annexin V staining of the cell surface
phosphatidylserine to identify the macrophages that under-
went apoptotic cell death. In sham-operated mice, 1% of
the peritoneal macrophages were annexin V–positive (Fig.
1 A). Administration of zVAD had no effect on the viabil-
ity of the macrophages in these mice. Similarly, there were
1% apoptotic macrophages isolated from CLP mice.
However, zVAD significantly increased annexin V–posi-
tive cells to 15% in CLP mice. Therefore, zVAD-
enhanced macrophage cell death in sepsis could contribute
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to the improved survival observed in zVAD-treated septic
mice (18).
We showed previously that zVAD promotes cell death
in LPS or lipoprotein-activated macrophages, but did not
promote cell death in flagellin- or CpG oligonucleotide–
treated macrophages (15). Because LPS and PG activate
macrophages via TLRs 4 and 2, respectively, we examined
whether TLR2 and TLR4 were required for macrophage
death in our system. Peritoneal macrophages were isolated
from wild-type, TLR2/, and TLR4/ mice, and chal-
lenged with LPS or PG in the presence or absence of
zVAD. As expected, LPS and PG stimulation led to macro-
phage death in the presence of zVAD (Fig. 1 B). TLR2/
macrophages were resistant to PG  zVAD, but not
LPS  zVAD–induced cell death, and TLR4/ macro-
phages were resistant to LPS  zVAD, but not PG 
zVAD–induced cell death. Thus, TLR2- or TLR4-medi-
ated signaling is required for zVAD-induced cell death in
the presence of their respective ligands. zVAD did not pro-
mote death of flagellin (a TLR5 ligand)- or CpG oligonu-
cleotide (a TLR9 ligand)–treated macrophages from the
wild-type, TLR2/, or TLR4/ mice (unpublished data).
In summary, zVAD, together with signaling initiated from
TLR2 or TLR4, can lead to macrophage cell death.
The murine macrophage cell line, RAW 264.7, has
many of the features of peritoneal macrophages, including
LPS responsiveness and cytokine production. LPS, PG,
flagellin, and CpG exerted the same profile of killing effects
on RAW 264.7 cells as on peritoneal macrophages in the
presence of zVAD (Fig. 1 C). Thus, RAW 264.7 cells were
used to study the mechanisms of zVAD-promoted cell
death in activated macrophages.
Induction of Nur77 Expression Correlated to the LPS 
zVAD-induced Macrophage Cell Death. Cell death can be
mediated by different mechanisms, including induction of
death genes, whose products, in turn, lead to cell death.
Because zVAD-promoted macrophage death is not medi-
ated by the classic caspase pathways, we asked whether
there is death gene induction during the stimulation of
RAW 264.7 cells with LPS  zVAD, but not with LPS or
zVAD alone. We analyzed mRNA and protein levels of
several genes (e.g., Nur77, p53, Rb, Bad, and Bax), whose
inductions are known to promote cell death. Of these, only
Nur77 was strongly induced in LPS  zVAD–treated
RAW 264.7 cells (Fig. 2, A and B). Fig. 2 A shows an RT-
PCR product of Nur77 that was detected in cells treated
with LPS  zVAD, but not in cells treated only with LPS
or zVAD. By using real-time PCR, we found the level of
Nur77 mRNA in LPS  zVAD–treated cells is 30–40-
fold higher than in the control, or LPS- or zVAD-treated
cells (Fig. 2 B). We compared the time courses of Nur77
induction (Fig. 2 B) and cell death (Fig. 2 C) after LPS 
zVAD treatment, and found that Nur77 induction is a pre-
lude to cell death, suggesting that Nur77 could be a trigger
of cell death.
Nur77 as a Causative Factor in the LPS  zVAD-induced
Macrophage Cell Death. To investigate if Nur77 contrib-
utes to cell death in LPS  zVAD–treated RAW 264.7
cells, we first examined whether Nur77 can cause death
of RAW 264.7 cells. It was reported that a Nur77 mu-
tant, lacking DNA binding domain (Nur77-DA), does
not localize in the nucleus as the wild-type Nur77 does
and can directly target mitochondria to trigger cell death
(31). Expression of the GFP–Nur77-DA fusion protein in
LNCaP cells was reported to cause death of 35% cells
(31). Expression of this putative dominant active mutant
in RAW 264.7 cells led to 25% cell death, and cell
death was not inhibited by zVAD (Fig. 2 D). This finding
indicates that Nur77 promotes caspase-independent cell
death in RAW 264.7 cells. Because zVAD has no effect
on Nur77-mediated cell death, Nur77 could be located
downstream of zVAD.
Figure 1. Induction of cell death by the pan-
caspase inhibitor zVAD in septic and LPS-acti-
vated macrophages. (A) CLP or sham-operated
ND4 mice were treated with zVAD or its vehi-
cle (DMSO) for 26–30 h. Macrophages in peri-
toneal isolates were gated by CD11b, F4/80,
and CD11c using flow cytometry, and the cell
death of macrophages was determined by an-
nexin V staining. (B) Peritoneal macrophages of
wild-type, TLR2/, or TLR4/ mice and
(C) RAW264.7 cells were treated for 12 h with
10 ng/ml LPS, 10 g/ml PG, 10 g/ml flagel-
lin, or 10 g/ml CpG oligonucleotide together
with or without 50 M zVAD as indicated.
The extent of cell death was measured by crys-
tal violet uptake of live cells as described in Ma-
terials and Methods. Results represent the
means 	 SE (n 
 3–4).
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A role for Nur77 in negative selection of T cells has been
demonstrated using dominant mutant transgenic mice (27).
The Nur77 knockout mouse has been generated, but T cell
apoptosis remains normal (36). This is probably due to
Nur77 family members compensating for the loss of Nur77
(37). To determine whether Nur77 is required for LPS 
zVAD–induced macrophage death, we isolated peritoneal
macrophages from wild-type and Nur77/ mice, and
tested their sensitivity to LPS  zVAD–induced cell death.
Unlike the situation with T cells, macrophage death was
influenced by Nur77 deletion. As shown in Fig. 2 E,
LPS  zVAD–induced cell death of Nur77/ macro-
phages was significantly less than that of wild-type macro-
phages. About sixfold increase in survival rate was found in
Nur77/ macrophages in comparison with wild-type
macrophages (Fig. 2 F). We suspect that the functional re-
dundancy of Nur77 family members may also affect mac-
rophage death because Nur77 deletion did not completely
prevent LPS  zVAD–induced cell death. These data dem-
onstrate that Nur77 is involved in LPS  zVAD–induced
cell death of macrophages.
Expression of Other Nur77 Family Members in LPS 
zVAD–treated Macrophages. Because a functional redun-
dancy of Nur77 family members has been suggested (37),
we investigated whether other Nur77 family members are
also induced by LPS  zVAD in peritoneal macrophages.
The proteins that exhibit a close structural relationship to
the orphan nuclear receptor, Nur77, are Nurr1 and Nor1
(38). Nur77, Nurr1, and Nor1 are not expressed, or are ex-
pressed at very low levels, in resting macrophages because
RT-PCR did not detect their mRNA (Fig. 3). As in the
case of Nur77, Nurr1 mRNA was induced in the mac-
rophages treated with LPS  zVAD, but not in the mac-
rophages treated with LPS or zVAD alone (Fig. 3, A and
B). Nor1 is different from Nur77 and Nurr1 in that LPS
alone is sufficient for its mRNA induction (Fig. 3 C).
Real-time PCR analysis reveals that Nur77 and Nurr1
mRNA were increased 75-fold and 60-fold, respec-
tively, after treatment with LPS  zVAD (Fig. 3, A and B,
right). Nor1 mRNA was induced 50-fold by either LPS
alone or LPS  zVAD (Fig. 3 C, right). These results indi-
cate that Nurr1 expression also correlates with macrophage
death induced by LPS  zVAD.
The Role of zVAD in Nur77 Induction Is to Prevent Degra-
dation of MEF2 Transcription Factors Whose Activity Is Re-
quired for Nur77 Expression. To further investigate the
mechanisms underlying LPS  zVAD–induced Nur77 ex-
pression, we first tried to identify the zVAD-mediated
changes that contributed to Nur77 induction. Because
zVAD is a pan-caspase inhibitor, one possible role of zVAD
in Nur77 induction is to prevent cleavage of the protein(s)
required for Nur77 induction. Caspases can cleave a num-
ber of proteins including MEF2 transcription factors (39,
40). MEF2 activity has been well-documented as being re-
quired for the expression of Nur77 proteins in T cells (41,
42). Therefore, we tested whether zVAD has any effect on
MEF2 activity in RAW 264.7 cells. As shown in Fig. 4 A,
treatment with zVAD or zVAD  LPS, but not LPS,
quickly increased MEF2 activity, which was measured by
EMSA using a 32P-labeled double-stranded probe contain-
Figure 2. Induction of Nur77 mRNA
and its involvement in cell death in
LPS  zVAD–treated RAW 264.7
cells. RAW 264.7 cells were treated
with 10 ng/ml LPS, 50 M zVAD, or
both for 9 h or indicated time periods.
(A) Total mRNA extraction and
RT-PCR of Nur77 mRNA were per-
formed as described in Materials and
Methods. An expected 1,494-bp band
was detected only in LPS  zVAD–
treated cells. (B) Real-time RT-PCRs
of Nur77 mRNA were performed as
described in Materials and Methods.
The results show a means 	 SE (n 
 4).
(C) PI-permeable cells were separated
by FACS® and the percentage of PI-
positive (dead) cells was plotted for dif-
ferent times. The results shown are the
means 	 SE (n 
 3). (D) RAW 264.7
cells were electrophoretically transfected
with vector control or expression vector
of a putative Nur77-dominant active
(Nur77-DA) mutant together with a
GFP expression vector. Cells were har-
vested 48 h after transfection. GFP ex-
pression was used to identify the trans-
fected cells using FACS®, and cell death in transfected cells was analyzed by PI staining using FACS®. Results show the means 	 SE (n 
 3). (E)
Peritoneal macrophages from Nur77/ and Nur77/ mice were treated with 50 M zVAD, 10 ng/ml LPS, or both for 12 h. The cells were examined
under microscope and photomicrographs of two experiments are shown. (F) The extent of cell death of Nur77/ or Nur77/ macrophages induced by
zVAD  LPS was measured using crystal violet uptake by living cells. The results show the means 	 SE (n 
 3).
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ing the consensus sequence of the MEF2 site. Thus, zVAD
has an effect on MEF2 transcription factors. There are four
members of the MEF2 family. We used real-time PCR to
measure the mRNA of MEF2A, MEF2B, MEF2C, and
MEF2D before and after zVAD treatment, showing that
there is no detectable increase in mRNA levels of these
MEF2 transcription factors (Fig. 4 B). MEF2B mRNA was
barely detectable and is not depicted. We also examined
samples treated with LPS  zVAD and obtained the same
result (unpublished data). These data indicate that zVAD
does not affect transcription or the mRNA stability of
MEF2 transcription factors. We examined protein levels of
the MEF2 transcription factors and found that MEF2A,
MEF2C, and MEF2D proteins were dramatically increased
in zVAD or LPS  zVAD, but not in samples treated with
LPS alone (Fig. 4 C). This indicates that zVAD itself can
increase MEF2A, MEF2C, and MEF2D proteins. The in-
duction of the MEF2 proteins occurred quickly and
reached their maximum within 45 min (Fig. 4 C). MEF2B
was not detected in RAW 264.7 cells (unpublished data).
zVAD was able to significantly increase the MEF2 isoforms
at concentrations as low as 25 M, but maximally between
50 and 100 M (Fig. 4 D).
We next explored the mechanism by which zVAD in-
duces MEF2 protein. Because there is no change at the
mRNA level, the increased protein level should be medi-
ated by increased protein translation or increased protein
stability. We treated RAW 264.7 cells with a protein syn-
thesis inhibitor, 10 M cyclohexamide, together with or
without zVAD. As shown in Fig. 5 A, MEF2A, MEF2C,
and MEF2D proteins were reduced after protein synthesis
was blocked. However, protein levels were maintained
when zVAD was included, suggesting that zVAD stabilizes
the MEF2 proteins. Caspases have been shown to cleave
many proteins (1). It seems that zVAD inhibits caspase ac-
tivity to prevent the degradation of MEF2 proteins. This
possibility is also suggested in recent reports that MEF2C
and MEF2D can be cleaved by caspases, but their subse-
quent degradation was not reported (40). We used a large
amount of cell lysate from resting RAW 264.7 cells and
found trace amounts of a short fragment of MEF2A, re-
ferred to as MEF2A(f) (Fig. 5 B). The cleavage is most
likely mediated by a caspaselike protease since zVAD treat-
ment inhibited the appearance of this fragment. To con-
firm that cleavage of MEF2A occurs in macrophages, we
used peritoneal macrophages to repeat this experiment. As
shown in Fig. 5 C, MEF2A is cleaved in the absence of
zVAD, but this cleavage is prevented when zVAD is
present. Thus, the MEF2 proteins are constitutively ex-
pressed and quickly degraded in resting macrophages, the
degradation is initiated by a caspaselike protease, and
zVAD inhibits caspase activity and prevents degradation of
MEF2 proteins.
Two MEF2 binding sites were identified in sequences
between 307 and 242 in the Nur77 promoter (Fig. 6
A). To demonstrate that MEF2 activity is indeed required
for Nur77 expression in RAW 264.7 cells, we used lu-
ciferase reporters. One luciferase reporter is driven by a
portion of the Nur77 promoter, which contains MEF2
sites, and another is an identical reporter except that the
MEF2 sites have been mutated. The structure of the re-
porter constructs is shown in Fig. 6 A. RAW 264.7 cells
were transfected with the wild-type or mutated reporter
plasmid, and then stimulated with zVAD, LPS, or LPS 
zVAD. Neither reporter was affected by zVAD treatment
(Fig. 6 B). LPS stimulation induced approximately fivefold
increase of the expression of both reporters. LPS alone did
not induce endogenous Nur77 expression, but induced the
Nur77 promoter driven reporter. This phenomenon is of-
ten seen. One possible interpretation is that the chromatin
structure influences endogenous gene expression that can-
not be mimicked in transiently transfected reporter genes.
Nevertheless, LPS stimulation alone did not discriminate
mutated MEF2 sites from the wild type. Similar to the en-
dogenous gene, expression of the Nur77 reporter gene was
significantly induced in cells costimulated with LPS and
zVAD. An important finding is that mutation of MEF2
Figure 3. mRNA level of Nur77 family members in peritoneal mac-
rophages before and after stimulation with LPS, zVAD, or LPS 
zVAD. (A–C) Peritoneal macrophages were treated with 10 ng/ml LPS,
50 M zVAD, or both for 2 h. Total RNA extraction and RT-PCR
were performed as described in Materials and Methods. The expected
1,494-, 647-, and 611-bp cDNA bands amplified from Nur77, Nurr1,
and Nor1 mRNA, respectively, were detected. Real-time RT-PCRs
were performed. The results are shown in right panels with the means 	
SE (n 
 3).
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sites in the promoter eliminated the effect of zVAD, indi-
cating that zVAD’s effect is through MEF2 transcription
factors. Thus, MEF2 transcription factors are the targets of
zVAD, and MEF2 activity is required, but not sufficient,
for Nur77 induction in macrophages.
Extracellular Signal-regulated Kinase (ERK) Pathway Acti-
vated by LPS Is Required for Nur77 Induction. LPS stimula-
tion in macrophages leads to activation of multiple signaling
pathways. To find out which LPS-activated signaling path-
ways participate in LPS  zVAD–induced Nur77 expres-
sion, our initial approach was to use various inhibitors to
search for the candidate(s) involved. Bisindolylmaleimide I,
a protein kinase C inhibitor, and Ly294002, a phosphati-
dylinositol-3 (PI3) kinase inhibitor, had no effect on LPS 
zVAD–induced cell death (Fig. 7 A). SB203580 (25 M), a
p38 inhibitor, enhanced LPS  zVAD–induced cell death.
U0126 (25 M), a Mek inhibitor, significantly blocked
ERK activation by LPS  zVAD (unpublished data) and
blocked the cell death induced by LPS  zVAD in RAW
264.7 cells (Fig. 7 A). To examine whether these inhibitors
have the same effect on LPS  zVAD–induced Nur77 ex-
pression, we measured Nur77 mRNA level in RAW 264.7
cells treated with LPS  zVAD in the presence of different
inhibitors. The effects of these inhibitors on Nur77 mRNA
levels correlate well with their effect on cell death (Fig. 7
B). These results suggest that the ERK pathway is required
for LPS  zVAD–induced Nur77 induction and cell death.
The ERK pathway can regulate a number of transcrip-
tion factors. There are several cis elements located in a con-
Figure 4. zVAD increases MEF2 proteins to induce
MEF2 transcription activity. (A) RAW 264.7 cells
were incubated with 10 ng/ml LPS, 50 M zVAD, or
both, for the indicated time periods. MEF2 activity was
measured by EMSA. (B) RAW 264.7 cells were incu-
bated with 50 M zVAD for the indicated time peri-
ods. Real-time RT-PCRs for MEF2 isoforms were
performed as described in Materials and Methods. The
results shown are the means 	 SE (n 
 3). (C) RAW
264.7 cells were incubated with LPS, zVAD, or both,
for the indicated time periods. Total cell extracts (20
g of protein/lane) were separated on SDS-PAGE and
immunoblotted with antibodies specific to MEF2 fam-
ily members. (D) RAW 264.7 cells were incubated
with different concentrations of zVAD for 45 min, and
the cell extracts (20 g of protein/lane) were separated
on SDS-PAGE and immunoblotted with antibodies
specific to MEF2 family members.
Figure 5. zVAD induces MEF2 protein level by blocking the degra-
dation. (A) RAW 264.7 cells were treated with 10 g/ml cyclohexamide
for 10 min, and then were treated with nothing or with 50 M zVAD
for the indicated time periods. Total cell extracts (40 g of protein/lane)
were separated on SDS-PAGE and immunoblotted with antibodies spe-
cific to MEF2 family members. (B and C) RAW 264.7 cells (B) or peri-
toneal macrophages (C) were incubated with LPS, zVAD, or both for
45 min. Total cell extracts (100 g of protein/lane) were separated on
SDS-PAGE and immunoblotted with antibodies specific to MEF2A. An
23-kD fragment of MEF2A was indicated as MEF2A(f). Films were
exposed for a prolonged time period to visualize the MEF2 proteins and
MEF2A(f).
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Figure 6. Mutation of MEF2
sites in the promoter of Nur77
abolished the effect of zVAD on
gene expression. (A) Illustration
of the sequence of the Nur77 re-
porter constructs. The putative
MEF2 binding sequences in the
Nur77 promoter and their mu-
tated sequences were shown.
The portion of Nur77 promoter
(307 to 242 nucleotide) was
conjugated to 5-end of the min-
imal Nur77 promoter sequences.
Nucleotides are numbered rela-
tive to the transcriptional start
site of genes. (B) Wild-type and
me2f mut reporter plasmids were
transfected into RAW 264.7
cells. After 24 h, cells were
treated with 50 M zVAD, 10
ng/ml LPS, or LPS  zVAD for
another 12 h. Transient expres-
sion of the reporter gene was de-
termined as described in Materi-
als and Methods.
served region of the Nur77 promoter that might possibly
respond to ERK activation (Fig. 8 A; references 43, 44).
To study the role of LPS in LPS  zVAD–induced Nur77
expression, we transiently transfected a reporter driven by
this portion of Nur77 promoter in RAW 264.7 cells. The
cells were stimulated with LPS, zVAD, or LPS  zVAD in
the presence or absence of the U0126, and reporter gene
expression was analyzed. As shown in Fig. 8 B, an approxi-
mately eightfold increase of the reporter gene activity was
detected in LPS- or LPS  zVAD–stimulated cells. The in-
duction of this reporter expression was abolished by the
U0126, indicating that the induction is dependent on the
ERK pathway. To further investigate which promoter mo-
tif is involved in the expression of the reporter gene, each
cis element was mutated and its effect on reporter gene ex-
pression was analyzed. Mild reduction was observed in mu-
tants of Ets (etsm), Rce (rcem), and Sp1 (sp1m; Fig. 8 C). The
most significant reduction was found in the Nap mutant
(napm). The level of reduction in reporter gene expression
by the Nap sequence mutation is similar to that by the
U0126 (Fig. 8, B and C). In addition, U0126 only had a
slight inhibitory effect on napm reporter expression in LPS-
treated RAW 264.7 cells. This data suggests that Nap is a
major target of the ERK pathway. Activation of Ets- and
Sp1-dependent transcription by ERK has been reported in
various cell types, including RAW 264.7 cells (45), and is
most likely also involved in Nur77 induction.
Discussion
A role of Nur77 in T cell death has been well-docu-
mented. Here, we show that Nur77 also has a role in the
caspase-independent cell death of macrophages. Similar to
T cells, Nur77 induction in macrophages requires costimu-
latory signals. Due to the difference between macrophages
and T cells, the death stimuli of these cells are also differ-
ent. Macrophages are activated when exposed to bacterial
wall components, such as LPS. A costimulus that leads to
cell death of LPS-activated macrophages is the pan-caspase
inhibitor zVAD. Nur77 is clearly involved in the cell death
Figure 7. Effects of various inhibitors in LPS  zVAD–induced Nur77
mRNA expression and cell death in RAW 264.7 cells. (A) RAW 264.7
cells were treated with 10 ng/ml LPS or 50 M LPS  zVAD in the ab-
sence or presence of 25 M SB203580, 25 M U0126, 10 M bisindolyl-
maleimide I, or 10 M Ly294002 for 12 h. PI-positive dead cells were
counted by FACS®. Results show the means 	 SE (n 
 4). (B) RAW 264.7
cells were treated with LPS  zVAD for 9 h in the absence or presence of
various inhibitors as above. The levels of mRNA for Nur77 were analyzed
by real-time PCR. Results show the means SE (n 
 2–3). The effectiveness
of U0126 in inhibition of LPS-induced ERK activation was confirmed by
Western blotting with anti–phospho-ERK1/2 antibody (not depicted).
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of macrophages for several reasons: its induction closely
correlates with LPS  zVAD–induced cell death (Fig. 2 A–
C); the putative dominant active Nur77 mutant causes
macrophage death (Fig. 2 D); and LPS  zVAD–induced
cell death is decreased significantly in macrophages from
Nur77 knockout mice (Fig. 2, E and F). We found that ac-
tivation of the ERK pathway by LPS is required for Nur77
induction and cell death (Figs. 7 and 8). Elevation in the
level of MEF2 transcription factors is a cellular event result-
ing from zVAD treatment (Fig. 4), and is required for
Nur77 induction and cell death. The integration of MEF2
activity with other transcription factors downstream of the
ERK pathway on the Nur77 promoter is essential for
Nur77 induction and cell death. ERK activation in acti-
vated macrophages is well-documented, involving Ras, raf,
and MEK (15, 46, 47). These results show for the first time
that MEF2 transcription factors are short-lived proteins in
macrophages and can be regulated at the level of protein
stability (Figs. 4 and 5). zVAD prevents cleavage of MEF2
proteins, and, therefore, increases MEF2 activity. The
mechanism of LPS  zVAD–induced macrophage death is
summarized in Fig. 9.
Because macrophages and T cells are different types of
cells, both in their origin and function, induction of the
same protein to elicit AICD in these two types of immune
cells was unexpected. Given that the same molecules are
involved in the cell death of macrophages and T cells, there
may be some common execution steps in each cell death
process. In support of this idea, both macrophage death and
negative selection of T cells have been shown to be
caspase-independent (15, 48, 49). Nur77 induction could
be a broadly common mechanism in caspase-independent
cell death. Although the activation signals in T cells and
macrophages are initiated from different cell surface recep-
tors, there is still some similarity of the intracellular signal-
ing events between T cells and macrophages that lead to
Nur77 induction. Activation of the ERK pathway and in-
creased activity of MEF2 transcription factors are required
for Nur77 induction in both T cells and macrophages, al-
though the activation mechanisms are different (41, 42).
The activation of ERK in T cells and macrophages is cer-
tainly initiated through different ligand–receptor interac-
tions. MEF2 is activated in T cells through the release of
the MEF2 protein from repressor Cabin1 by a calcium-
Figure 8. The effect of the
mutation of different cis elements
in the Nur77 promoter on LPS-
induced Nur77 reporter gene
expression. (A) Illustration of the
sequence of the Nur77 promoter
and its mutants. (B) Wild-type
Nur77 promoter reporter plas-
mids were transfected into RAW
264.7 cells. After 24 h, cells were
treated with or without 10 ng/
ml LPS, 50 M zVAD, or 25
M LPS  zVAD in the pres-
ence or absence of U0126 for
another 12 h. The expression of
the reporter gene was deter-
mined as described in Materials
and Methods. (C) Wild-type and
mutated Nur77 promoter plas-
mids were transfected into RAW
264.7 cells. After 24 h, cells were
treated with or without 10 ng/
ml LPS for another 12 h. The
expression of the reporter gene
was determined.
Figure 9. The proposed mechanism of LPS + zVAD–induced mac-
rophage cell death. The transcription factor downstream of the LPS-acti-
vated ERK pathway cooperates with zVAD-stabilized MEF2 transcription
factor to induce Nur77 expression. The Nur77 induction leads to the cell
death of activated macrophages.
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dependent mechanism (42), whereas the activation of
MEF2 transcription factors in macrophages is due to the in-
crease of the MEF2 by protein stabilization. An increase in
macrophage intracellular calcium concentration has no ef-
fect on MEF2 activity, Nur77 expression, or cell death
(unpublished data). The zVAD effect on the MEF2 protein
in T cells did not appear to be the same as in macrophages.
Therefore, the effect of zVAD on protein stabilization may
be cell-type specific.
Both the transcription activity of Nur77 and its translo-
cation to the mitochondria are implicated in cell death (30,
31). Phosphorylation of Nur77 on Ser-350 by Akt was
shown to inhibit T cell death by suppressing the DNA
binding activity of Nur77 and stimulating Nur77 associa-
tion with 14-3-3 (50). Activation of Akt in macrophages
by LPS also has been reported (51). It is possible that Akt
prevents death signals in LPS-activated macrophage death.
We treated LPS-activated cells with inhibitors of PI3 ki-
nase, the upstream kinase of Akt, and did not find any in-
fluence on cell viability. We compared phosphorylation of
Akt in macrophages stimulated with LPS and LPS 
zVAD, and found no difference (unpublished data), sug-
gesting that zVAD did not influence the Akt pathway to
promote cell death. Direct phosphorylation of Nur77 by
ERK was reported (52), but its physiological relevance is
unclear. The ERK pathway may not only be required for
Nur77 induction, but could also influence Nur77 function
by direct phosphorylation. Nuclear factor (NF)-B is an-
other survival pathway activated by LPS in macrophages
(53). It has been shown that in short time periods (within 2
h), IB- degradation and nuclear translocation of NF-B,
induced by LPS in RAW 264.7 cells, are not influenced by
zVAD at 50 M concentration (15). Yet in another report,
it is documented that the NF-B reporter gene activity is
inhibited at a later time (8 h) by zVAD at 100-M concen-
tration (54). These contrasting observations may be due to
the different doses or exposure time of zVAD used. The
“survival pathways” do not appear to play a role in macro-
phage death in our system.
Nurr1 and Nor1 are orphan nuclear receptors that be-
long to the same family as Nur77. These proteins exhibit a
close structural relationship and may function redundantly
(38). Because Nur77 knockout cannot completely prevent
LPS  zVAD–induced macrophage death (Fig. 2 F), the
other Nur77 family members may be able to compensate
for the function of Nur77 in LPS  zVAD–induced mac-
rophage death. Nor1 may not be involved in LPS 
zVAD–induced cell death because its expression does not
need dual stimuli (Fig. 3 C). Nurr1 is a candidate that com-
pensates the function of Nur77 in Nur77 knockout cells
because its induction also requires dual stimuli (Fig. 3 B).
Sequence analysis reveals that there are cis elements such as
CREB, CarG box, and Sp-1 in the Nurr1 promoter that
can be regulated by LPS signaling (55). However, we were
unable to find a typical MEF2 site, suggesting a different
mechanism was used by zVAD to costimulate Nurr1 ex-
pression. Determining the target of zVAD in Nurr1 induc-
tion is a subject for further investigation.
Macrophage death has been observed in a number of
inflammatory diseases. Although the lifespan of macro-
phages is modulated during inflammation, there are not
many studies addressing the effect of macrophage death on
the outcome of inflammatory diseases. Administration of
zVAD has been shown to significantly increase the sur-
vival rate of septic mice (18), but zVAD’s effect on
macrophages was not evaluated. Our data show that
zVAD-enhanced macrophage death in septic mice pro-
vides important information for understanding the in vivo
role of caspase inhibition. Inducible activation of caspases
is a current focus in studies of caspase-mediated cellular re-
sponses. Our data indicate that caspaselike proteins also
function in resting cells by maintaining MEF2 proteins at
low levels. Inhibition of constitutive turnover of MEF2
transcription factors in macrophages by zVAD suggests
that caspaselike proteases have roles in controlling the sta-
bility of some short-lived proteins. The basal activity of
caspase(s) probably plays a key role in controlling the sus-
ceptibility of macrophages to AICD. It would be very in-
teresting to find the identity of this caspaselike protease
and study its role in the fate of macrophages.
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